Introduction
Atherosclerosis is a complex disease in which many factors contribute to the development of lesions 1) . Vascular smooth muscle cell (VSMC) proliferation and migration are the pivotal events of atherogenesis and play an essential role in atherosclerotic plaque progression 2) . Under the state of chronic inflammation observed in atherosclerosis, the VSMC phenotype shifts from a quiescent contractile state to an active synthetic state. Synthetic phenotypes of VSMCs proliferate and migrate from the medial layer of the vessel 28) . Furthermore, hypochlorite-induced oxidative stress elevates the ability of HDL to promote breast cancer metastasis 29) . Meanwhile, oxidized HDL is dysfunctional in promoting endothelial repair both in vitro and in the reendothelialization of injured carotid arteries 30) . However, whether ox-HDL also promotes the proliferation and migration of VSMCs and aggravates the progression of atherosclerosis remains unknown. In the present study, we demonstrated that ox-HDL induces the proliferation and migration of VSMCs by activating NADPH oxidase and promoting the production of ROS, from which we conclude that ox-HDL is a key risk factor for restenosis of the coronary artery following percutaneous transluminal coronary angioplasty (PTCA) or percutaneous coronary intervention (PCI) in CHD patients.
Oxidized High-Density Lipoprotein Induces the Proliferation and Migration of Vascular Smooth Muscle Cells by Promoting the Production of ROS

Materials and Methods
Animals and Reagents
All procedures were approved by the Ethics Committee for the Use of Experimental Animals at Xiamen University, and all experiments followed the institution's instructions for animal care and use. Male Sprague-Dawley (SD) rats (120-160 g) were provided by the Experimental Animal Center of Xiamen University and used to isolate aortic smooth muscle cells. Dulbecco's modified Eagle's medium (DMEM), trypsin and fetal bovine serum (FBS) were purchased from Gibco Co. (Carlsbad, CA, USA). Diphenyleneiodonium chloride (DPI), N-acetyl-L-cysteine (NAC), 2', 7'-dichlorofluorescindiacetate (DCFH-DA) and crystal violet were purchased from Sigma (St. Louis, MO, USA). The Cell Counting Kit-8 (CCK-8) was purchased from Enzo Biochem, Inc. (Farmingdale, NY, USA). The Rac1/Cdc42 Activation Assay Kit and Transwell chamber with 8-μm pore polycarbonate membranes were obtained from Millipore Co. (Billerica, MA, USA). The NADP/NADPH Assay Kit was obtained from Abcam Co. (Cambridge, UK). The antibody to total Rac1 was purchased from SAB Biotech (College Park, MD, USA), and the antibody to β-actin was obtained from Beyotime (Haimen, China). All other chemicals and reagents were obtained from commercial sources and of analytical grade.
Cell Culture
Vascular smooth muscle cells (VSMCs) were isolated from the thoracic aortas of male SD rats as previously described 6) . The VSMCs were grown in DMEM medium supplemented with 10% FBS and antibiotics into the intima, resulting in the development of neointimal hyperplasia, which is implicated in coronary restenosis after angioplasty in patients with coronary heart disease (CHD) 2, 3) . The proliferative and migratory activities of VSMCs are regulated by many growth promoters and inflammatory factors, such as platelet-derived growth factor (PDGF), endothelin-1 (ET-1), angiotensin Ⅱ (Ang-Ⅱ) and oxidized low-density lipoprotein (ox-LDL) [4] [5] [6] [7] . Therefore, the use of strategies aimed at inhibiting the proliferation and migration of VSMCs would prevent the development of atherosclerotic plaque and subsequent CHD.
High-density lipoprotein (HDL) is appropriately recognized as the major atheroprotective particle in plasma 8) . The protective effects of HDL are primarily attributed to its ability to promote reverse cholesterol transport (RCT) in addition to its antioxidant, antiinflammatory and antithrombotic activities 9, 10) . HDL also exerts several beneficial effects on the vasculature, including preventing endothelial dysfunction and suppressing VSMC proliferation and migration 11, 12) . HDL inhibits VSMC migration via the sphingosine-1-phosphate (S1P)-2 receptor induced by PDGF 13) . Sun et al. also showed that endothelial lipase (EL) inactivation increases the amount of plasma HDL particles that can inhibit VSMC growth and migration induced by Ang-Ⅱ; however, EL overexpression decreases the HDL concentration, which increases the proliferation and migration of cultured VSMCs 14) . Meanwhile, increasing evidence has shown that HDL can lose its protective properties and even develop proinflammatory and proatherogenic phenotypes in the setting of systemic inflammation, including conditions such as atherosclerosis, diabetes mellitus and metabolic syndrome [15] [16] [17] . Dysfunctional HDL has become a key diagnostic and therapeutic target in cardiovascular disease 18) . The dysfunctional properties of HDL in systemic inflammation are associated with specific chemical modifications and structural changes, including the oxidation of phospholipids and apolipoproteins within HDL [19] [20] [21] . Several studies have shown that oxidized HDL (ox-HDL) loses its ability to stimulate cholesterol efflux from foam cells 22, 23) . In addition, ox-HDL can induce reactive oxygen species (ROS) production 24) and upregulate the expression of several proinflammatory and prothrombotic genes, including tumor necrosis factor-alpha (TNF-α), cyclooxygenase-2 (COX-2) and plasminogen activator inhibitor-1 (PAI-1) [25] [26] [27] , which elevates the risk of cardiovascular disease and accelerates the progression of atherosclerosis.
We also previously demonstrated that ox-HDL has an increased ability to induce the proliferation,
Transwell Migration Assay
The degree of cell migration was determined using a 24-well Transwell plate containing polycarbonate 8-μm pore membrane filters. Serum-starved VSMCs mixed with N-HDL or ox-HDL at different concentrations were seeded in the upper wells (5×10 4 cells per 200 μL of serum-free DMEM with N-HDL or ox-HDL), while the lower wells were filled with 800 μL of DMEM containing 10% FBS. The cells were allowed to migrate across the porous filters for six hours at 37 ℃. After fixing with 4% paraformaldehyde in PBS and staining with crystal violet, the nonmigrating cells on the upper surface of the filter were scraped, and the number of cells that had migrated to the lower side of the filter was counted in three random 100× fields per well using light microscopy (Nikon, Tokyo, Japan).
Scratch-Wound Assay
VSMCs were grown to 80% confluence in 6-well plates. The confluent monolayer was scratched gently with 200-μL pipette tips. The cells were rinsed twice with PBS buffer to remove cellular debris, and the linear wound was recorded. The VSMCs were then incubated with various doses of N-HDL or ox-HDL for 48 hours in DMEM media with 0.1% FBS. Following incubation, cell images were obtained, and the number of cells that had migrated into the wound space was manually counted in three random 100× fields per well using light microscopy (Nikon).
Measurement of Intracellular ROS
The intracellular ROS levels were detected using the oxidant-sensitive probe 2', 7'-dichlorofluorescein diacetate (DCFH-DA) 4) . VSMCs were grown on glass coverslips in 35-mm dishes and cultured in serum-free DMEM for 24 hours. Subsequently, the cells were washed twice with PBS and incubated with 5 μmol/L of DCFH-DA for 30 minutes. The cells were then incubated with 50 μg/mL of N-HDL or ox-HDL for 0, 5, 15, 30, 60, 120 and 240 minutes. Thereafter, the relative DCF fluorescence intensity was detected at the different time points mentioned above using fluorescent microscopy (Nikon). The examination wavelength was 488 nm and the emission wavelength was 530 nm for DCF. The fluorescence intensity of the stained cells was determined using Image-Pro Plus/ IOD.
Rac1 Activation Assay
An equal amount of proteins (500 mg) was used to assess the GTP-bound Rac1 levels using the p21-activated protein kinase p21 binding domain immobi-(100 units/mL of penicillin, 100 μg/mL of streptomycin) at 37 ℃ and maintained in an atmosphere of 5% CO2 and 95% air. Cells at passages 4-6 were used for further experiments. Generally, the cells were starved in serum-free DMEM for 24 hours before incubation with HDL or ox-HDL. The VSMCs were identified using immunofluorescence with a specific monoclonal anti-α-actin antibody.
HDL Isolation from Human Plasma
Fresh plasma was provided from healthy volunteers after overnight fasting. HDL (1.063-1.210 g/ mL) was isolated via ultracentrifugation as previously described 31) . Briefly, the plasma density was adjusted to 1.3 g/mL with KBr, and saline (1.006 g/mL) was layered over the adjusted plasma to form a discontinuous NaCl/KBr density gradient. The sample with the gradient was centrifuged at 350,000 g for 3.5 hours at 4 ℃. HDL was collected, dialyzed with PBS, sterilized through a 0.22-μm filter and stored in the dark at 4 ℃ for use. The purity of HDL was evaluated using 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and quantified by measuring the apoA-I content using nephelometry.
HDL Oxidation
Ox-HDL was prepared by exposing the HDL to 5 μM of CuSO4 for 24 hours at 37 ℃ in vitro 25) . The oxidation was terminated by adding ethylene diamine tetraacetic acid (EDTA) to a final concentration of 1 mg/mL, followed by dialyzing against PBS for 48 hours to remove the EDTA. The solution was then sterilized by passing it through a 0.22-μm filter. The extent of HDL oxidation was determined according to the level of thiobarbituric acid-reactive substances (TBARS), and the protein concentration was measured using the Bradford assay 22) .
Cell Proliferation Assay
A CCK-8 cell viability assay was used to evaluate cell proliferation, following the manufacturer's instructions. Briefly, VSMCs were seeded at 3×10 3 cells/well in 96-well plates. After the cells reached 70-80% confluence, they were incubated with serum-free DMEM media for an additional 24 hours. The VSMCs were then treated with native HDL (N-HDL) or ox-HDL at varying concentrations for 24 hours to stimulate cell proliferation. Subsequently, 10 μL of CCK-8 reagent was added to each well, and the cells were further incubated for two hours at 37 ℃. The absorbance was read at 450 nm using a spectrophotometric plate reader.
p＜0.05 were considered to be statistically significant ( 
Results
Ox-HDL Induces the Proliferation of VSMCs
To investigate whether ox-HDL induces the proliferation of VSMCs, we incubated VSMCs with 50 μg/mL of native HDL (N-HDL) or ox-HDL for 24 hours and assayed the proliferation of VSMCs using the CCK-8 kits. As anticipated, ox-HDL significantly promoted the proliferation of VSMCs; however, N-HDL had no effect on VSMC proliferation (Fig. 1A) . Even high doses of N-HDL had almost no proliferative effect on the VSMCs (Fig. 1B) . To further identify whether the proliferative effects of ox-HDL were dosedependent, we treated VSMCs with different doses of ox-HDL (25, 50 and 100 μg/mL) for 24 hours. We found that the proliferative function of ox-HDL was related to its concentration (Fig. 1C) . Therefore, compared with N-HDL, ox-HDL has a much stronger effect on VSMC proliferation.
Ox-HDL Induces the Migration of VSMCs
To confirm whether ox-HDL also has an influence on the migration of VSMCs, we treated VSMCs with 50 μg/mL of N-HDL or ox-HDL for six hours and counted the number of VSMCs migrating through the Transwell membrane filters. Consistently, ox-HDL significantly facilitated the migration of VSMCs ( Fig. 2A and B) . However, 50 μg/mL of N-HDL did not promote VSMC migration, and instead slightly inhibited the migration of the VSMCs, although not significantly ( Fig. 2A and B) . Subsequently, we found lized onto glutathione-agarose beads following the manufacturer's instructions. The extent of Rac1 activation (GTP-Rac1) was expressed as the ratio of the density of the GTP-Rac1 band to that of the total amount of Rac1 in each sample.
Western Blot Analysis
Proteins from the Rac1 activation assay described above were separated via 12% SDS-PAGE and blotted onto a polyvinyldifluoride membrane. A mouse monoclonal antibody to GTP-Rac1 (1:1000), rabbit polyclonal antibody to total Rac1 (1:1000) and mouse monoclonal antibody to β-actin (1:1000) were used as the primary antibodies. The specific immunoreactive blots were detected with electrochemiluminescence and analyzed using the Quantity One 1-D Analysis Software program (Bio-Rad, Hercules, CA, USA).
Measurement of the NADPH Oxidase Activity
The activity of NADPH oxidase was measured using an NADP 
Statistical Analysis
Each experiment was repeated at least three times. The data are presented as the mean±SEM. Differences were compared with two-tailed Student's t -test or a one-way analysis of variance (ANOVA) using the GraphPad Prism (5.0) software package. Values of A: VSMCs were incubated with PBS, N-HDL (50 μg/mL) or ox-HDL (50 μg/mL) for 24 hours, and the proliferation of the VSMCs was assayed using CCK-8 kits. B and C: VSMCs were incubated with PBS, 25, 50 and 100 μg/mL of N-HDL (B) or 25, 50 and 100 μg/mL of ox-HDL (C) for 24 hours, and the proliferation of the VSMCs was assayed using CCK-8 kits. The data are presented as the mean±SEM of three separate experiments. 
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wound healing in VSMCs following scratch assays.
Ox-HDL Induces the Production of ROS in VSMCs
To investigate whether ROS were involved in the proliferation and migration of VSMCs induced by ox-HDL, we evaluated the production of ROS in VSMCs triggered by N-HDL and ox-HDL. We treated VSMCs with 50 μg/mL of N-HDL or ox-HDL for different time intervals and monitored the intracellular oxidation of DCFH-DA based on the fluorescence intensity. Our results showed that, compared with that observed in the control group, ox-HDL remarkably increased the production of intracellular ROS in the cultured VSMCs in a time-dependent manner, with the formation of ROS peaking at 15 minutes (Fig. 4A  and B) . However, N-HDL had no effect on ROS generation ( Fig. 4A and B) . These results led to the conclusion that ox-HDL is a strong inducer of ROS production in VSMCs.
that 100 μg/mL of N-HDL inhibited the Transwell migration of the VSMCs, although low doses of N-HDL did not influence VSMC migration (Fig. 2C  and D) . However, the promigratory effects of ox-HDL were dose-dependent ( Fig. 2E and F) . Therefore, compared to N-HDL, ox-HDL significantly promotes the migration of VSMCs.
Ox-HDL Promotes Wound Healing in VSMCs
To further confirm the promigratory effects of ox-HDL, we evaluated the migration of VSMCs using a wound-healing assay and obtained results similar to those of the Transwell migration assay. We found that ox-HDL significantly promoted wound healing in the VSMCs (Fig. 3A and B) ; this effect was also dosedependent ( Fig. 3E and F) . However, N-HDL had almost no effect on wound healing in the VSMCs (Fig. 3A) , even at a dose of 100 μg/mL (Fig. 3C and  D) . Therefore, we concluded that ox-HDL promotes A and B: VSMCs were incubated with PBS, N-HDL (50 μg/mL) or ox-HDL (50 μg/mL) for six hours, and the migration of the VSMCs was assayed using a Transwell membrane filter. C, D, E and F: VSMCs were incubated with PBS, 25, 50 and 100 μg/mL of N-HDL (C and D) or ox-HDL (E and F) for six hours, and the migration of the VSMCs was assayed using a Transwell membrane filter. The number of cells that had translocated to the lower layer was counted after staining with crystal violet (B, D and F). The data are presented as the mean±SEM of three separate experiments. tently, ox-HDL remarkably increased the activity of NADPH oxidase; however, DPI significantly inhibited the NADPH oxidase activity induced by ox-HDL in the VSMCs (Fig. 5C, D and E) . These results led to the conclusion that the generation of ROS induced by ox-HDL in VSMCs is derived from the activation of NADPH oxidase triggered by ox-HDL and that DPI effectively inhibits the NADPH oxidase activity and ROS production induced by ox-HDL in VSMCs.
NAC Inhibits the Production of ROS Induced by Ox-HDL in VSMCs
NAC, as a ROS scavenger, can clear intracellular ROS. To detect whether NAC scavenges the intracellular ROS generated by ox-HDL, we preincubated VSMCs with 20 mmol/L of NAC for 30 minutes, then treated the VSMCs with 50 μg/mL of ox-HDL for 15 minutes. The level of intracellular ROS production was detected by monitoring the oxidation of
DPI Inhibits the Production of ROS and the Activation of NADPH Oxidase Induced by Ox-HDL in VSMCs
DPI, a specific inhibitor of NADPH oxidase, inhibits the activation of NADPH oxidase and the generation of intracellular ROS. To detect whether DPI inhibits NADPH oxidase activation and ROS production in VSMCs induced by ox-HDL, we preincubated VSMCs with 10 μmol/L of DPI for two hours, then treated the VSMCs with 50 μg/mL of ox-HDL for 15 minutes to assay the production of ROS and the activation of NADPH oxidase. The level of ROS production was assayed by monitoring the oxidation of DCFH-DA according to the fluorescence intensity. The NADPH oxidase activity was detected using a Rac1 pull-down assay and the intracellular NADP ＋ /NADPH ratio. Our results showed that DPI significantly inhibited the generation of ROS induced by ox-HDL in the VSMCs (Fig. 5A and B) . Consis- hours. Subsequently, the proliferation of VSMCs was assayed using the CCK-8 kits, as described above. We found that NAC significantly inhibited the proliferation of VSMCs induced by ox-HDL (Fig. 7) . Meanwhile, NAC did not cause any changes in the proliferation of VSMCs treated with N-HDL (Fig. 7) . Therefore, as a ROS scavenger, NAC effectively suppresses the proliferation of VSMCs triggered by ox-HDL.
NAC Inhibits the Migration of VSMCs Induced by Ox-HDL
To detect whether NAC also inhibits the migration of VSMCs induced by ox-HDL, we pretreated VSMCs with 20 mmol/L of NAC for 30 minutes, then DCFH-DA according to the fluorescence intensity, as described above. The results suggested that the increased ROS production induced by ox-HDL can be dramatically prevented by NAC, supporting the conclusion that the incubation of VSMCs with ox-HDL is associated with increased ROS formation (Fig. 6A and B) . Furthermore, NAC hardly interfered with the basal ROS production in the VSMCs, even when mixed with N-HDL ( Fig. 6A and B) . Therefore, NAC effectively inhibits the production of ROS induced by ox-HDL in VSMCs.
NAC Inhibits the Proliferation of VSMCs Induced by Ox-HDL
To further investigate whether NAC inhibits the proliferation of VSMCs, we preincubated VSMCs (Fig. 8A and B) , but also in the wound scratch assay (Fig. 8C and D) . However, in both applied the same procedures as those used in the Transwell migration and wound-healing assay experiments. Our results showed that, consistent with that observed for the inhibition of VSMC proliferation induced by VSMCs were preincubated with or without 10 μmol/L of DPI for two hours and subsequently treated with PBS, 50 μg/mL of N-HDL or 50 μg/mL of ox-HDL for 15 minutes. A: Fluorescent images of the cells were obtained using a fluorescence microscope (×400). B: The intensity of the DCF fluorescent images of the stained cells was quantified using Image-Pro Plus/IOD. C: GTP-Rac1 proteins were detected using the Rac1 pull-down assay and Western blotting. D: The extent of GTP-Rac1 was analyzed as the ratio of the density of the GTP-Rac1 band to that of the total amount of Rac1. E: The activation of NADPH oxidase was measured using NADP ＋ /NADPH ratio assay kits. The data are presented as the mean±SEM of three separate experiments. (Fig. 8A and B) and the scratch assay (Fig. 8C and D) , NAC had almost no effect on the VSMC migration induced by N-HDL. Therefore, NAC also effectively inhibits the migration of VSMCs induced by ox-HDL.
Discussion
Numerous studies have reported the presence of ox-HDL in atheromatous plaques as well as in plasma in animals and patients with CHD; however, the role of ox-HDL in the pathogenesis of atherosclerosis and restenosis following coronary angioplasty is not well established 20, 32) . In the present study, we demonstrated that ox-HDL, but not N-HDL, is a potent promoter of the proliferation and migration of VSMCs. The proproliferative and promigratory effects of ox-HDL were found to be positively correlated with intracellular NADPH oxidase activation and ROS production. enhances the proliferation, migration and invasion of breast cancer cells, while hypochlorite-induced oxidative stress elevates the capability of HDL to promote breast cancer metastasis, which demonstrates that ox-HDL and oxidative stress play essential roles in the proliferation and migration of cells 28, 29) . In this study, our results showed that compared with N-HDL, ox-HDL significantly promoted the proliferation of VSMCs in a dose-dependent manner (Fig. 1) . Accordingly, ox-HDL also facilitated the migration of VSMCs in the Transwell assay and wound-healing experiments in a dose-dependent manner ( Fig. 2 and Fig. 3) . Taken together, these results indicate that ox-HDL promotes neointimal growth and aggravates narrowing of the vessel lumen in CHD patients. Tamama et al. proved that native HDL inhibits VSMC migration via the S1P2 receptor induced by PDGF 13) . In addition, increasing the plasma HDL content in endothelial lipase (EL) knockout mice more potently inhibits the The synthetic phenotype of VSMC is capable of proliferating and migrating from the tunica media to the intima of the vessel, contributing to neointima genesis and extracellular matrix (ECM) deposition in the vessel wall and resulting in the narrowing of the vessel lumen after coronary angioplasty or stenting 3) . Although the proliferation and migration of VSMCs and presence of synthesized ECM proteins accelerate the repair of tissue and enhance the stabilization of atherosclerotic plaque, the activation of inflammatory and immune cells in the plaque may lead to intimal VSMC apoptosis, which makes the fibrous cap thinner and promotes plaque rupture 2, 3) . As a major atheroprotective element in plasma, HDL undergoes oxidative modification of its phospholipids and apolipoproteins during systemic inflammation and consequently loses its protective properties, even becoming a proinflammatory and proatherogenic factor 8, 16, 19) . In previous studies, we demonstrated that ox-HDL (Fig. 5) . Furthermore, Mahadevan et al. demonstrated that an enhanced intrinsic antioxidant capacity may promote VSMCs to resist migration against ox-LDL and Ang-Ⅱ 43) . N-acetylcysteine (NAC) is an effective ROS scavenger that inhibits PDGF-and ox-LDL-stimulated ROS production, ERK1/2 and p38 MAPK phosphorylation and NF-kappa B activation, which subsequently blocks the proliferative and hypertrophic pathways in VSMCs 4, 7) . In the present study, we found that NAC, as an antioxidant, also decreases the generation of intracellular ROS induced by ox-HDL (Fig. 6) . Meanwhile, NAC almost completely blocks the proliferation and migration of VSMCs triggered by ox-HDL ( Fig. 7 and 8) .
In summary, HDL may be viewed as a shuttle that can be either anti-inflammatory or proinflammatory, depending on its quality 16) . In research aiming to retard the development of atherosclerotic diseases, dysfunctional HDL has become a key diagnostic and therapeutic target in patients with cardiovascular disease 18) . The major finding of this study is that ox-HDL facilitates the activation of NADPH oxidase and the generation of ROS in VSMCs, thereby promoting the proliferation and migration of VSMCs, which aggravates narrowing of the vessels following coronary angioplasty and stent placement. Consequently, we speculate that it may be possible to employ effective antioxidants to inhibit HDL oxidation and improve the quality of HDL in patients with atherosclerosis or systemic inflammation, which may constitute a novel therapeutic strategy for controlling cardiovascular diseases in the near future.
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VSMC proliferation and migration induced by Ang-Ⅱ; however, decreasing the HDL concentration in EL transgenic mice enhances proliferation and migration in cultured VSMCs 14) . Our results are also consistent with the conclusion that N-HDL does not promote VSMC proliferation or migration (Fig. 1, 2 and 3) .
Several studies have clearly identified that intracellular ROS are involved in many pathophysiological processes in patients with cardiovascular disease, including the regulation of VSMC proliferation, migration, contraction, differentiation and apoptosis 33, 34) . Recent evidence suggests that many other proinflammatory factors aggravate the development of atherosclerosis and modulate the VSMC function through the production of ROS 35, 36) . Shimizu et al. and Wedgwood et al. showed that PDGF and ET-1 induce the generation of ROS and promote the proliferation and migration VSMCs 4, 5) . Similarly, Ang-Ⅱ and ox-LDL also promote the production of ROS in VSMCs, which enhances the growth and migration of VSMCs and aggravates the progression of atherosclerosis 6, 7) . In addition, intracellular ROS promote the activation of NFkappa B, phosphorylation of Akt, ERK1/2 and p38 MAPK and proliferation and migration of VSMCs 4, 7, 37) . Meanwhile, Satoh et al. demonstrated that ROS promote the production of Cyclophilin A (CyPA), which stimulates VSMC proliferation and migration both in vitro and in vivo 38) . Therefore, the strong relationship between oxidant stress and vascular remodeling establishes a connection between ROS production and VSMC proliferation and migration. Matsunaga et al. reported that ox-HDL induces a significant dose-dependent increase in ROS production in human umbilical vein endothelial cells 24) . In the present study, we found that ox-HDL also promotes the generation of ROS in a time-dependent manner in VSMCs (Fig. 4) . Robbesyn et al. indicated that HDL prevents the intracellular ROS increase triggered by ox-LDL in VSMCs 7) . Furthermore, Tolle et al. demonstrated that HDL inhibits NAD(P)H oxidase-dependent ROS generation in VSMCs via the S1P1 and S1P3 receptors 39) . Our study also found that native HDL does not induce ROS production in VSMCs (Fig. 4) .
It is well recognized that CD36 is a receptor for ox-HDL 40) . Moreover, less ROS is produced in the vessel walls of CD36 knockout mice than in wild-type mice following chemically induced arterial injury 41) . These results suggest that CD36, as a receptor of ox-HDL, contributes to ROS generation in VSMCs. NADPH oxidase is the major source of intracellular ROS, and inhibiting the expression of NADPH oxidase suppresses the production of ROS in VSMCs 42) . We also found that DPI, a specific inhibitor of
